AQR Capital Management’s Akoya BioSciences AKYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-36,409
Closed -$47.3K 3462
2025
Q2
$47.3K Buy
36,409
+11,152
+44% +$13.4K ﹤0.01% 3242
2025
Q1
$35.1K Buy
25,257
+14,203
+128% +$31.1K ﹤0.01% 3101
2024
Q4
$25.3K Buy
+11,054
New +$29.3K ﹤0.01% 2840

AQR Capital Management's AKYA Position: Q3 2025 in Review

AQR Capital Management sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 36,409 shares — an estimated $47.3K sold.

AQR Capital Management first reported a position in AKYA in Q4 2024 and held it in 3 quarters. The position peaked at $47.3K in Q2 2025. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

  • AQR Capital Management reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 36,409 Akoya BioSciences shares in Q3 2025, an estimated $47.3K.
  • AQR Capital Management first reported a position in Akoya BioSciences in Q4 2024 and held it in 3 quarters.
  • AQR Capital Management's Akoya BioSciences position peaked at $47.3K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.